Anti-angiogenic agents in Non-Small-Cell Lung Cancer (NSCLC): a perspective on the MONET1 (Motesanib NSCLC Efficacy and Tolerability) study JOURNAL OF THORACIC DISEASE Das, M., Wakelee, H. 2012; 4 (6): 558-561

View details for DOI 10.3978/j.issn.2072-1439.2012.10.02

View details for Web of Science ID 000314790400004

View details for PubMedID 23205278

View details for PubMedCentralID PMC3506785